BackLB PharmaceuticalsCommon Stock Overview

LB PharmaceuticalsCommon Stock Long Term Debt

Latest long-term debt for LBRX: $2.7M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$2.74M

Peer average

Loading

LB PharmaceuticalsCommon Stock Long Term Debt History

Loading

LB PharmaceuticalsCommon Stock vs. peers: Long Term Debt Comparison

Loading

LB PharmaceuticalsCommon Stock Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

LB PharmaceuticalsCommon Stock (LBRX) FAQ

LB PharmaceuticalsCommon Stock (LBRX) currently reports a long-term debt of $2.7M as of March 2026. Use the charts on this page to explore LB PharmaceuticalsCommon Stock's long-term debt history and peer comparisons.

LB PharmaceuticalsCommon Stock reported $2.7M in long-term debt as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $2.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LB PharmaceuticalsCommon Stock, and consider following LBRX for alerts when major investors trade the stock.

LB PharmaceuticalsCommon Stock is classified in the Healthcare sector. On long-term debt, it currently shows $2.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBRX with unrelated industries.